Results 191 to 200 of about 199,578 (301)

Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease. [PDF]

J Neurochem
Witzig V, Pjontek R, Tan SKH, Schulz JB, Holtbernd F.   +4 more
europepmc   +1 more source

Impact of Environmental Exposure on Infant Sleep : The Exposome Approach

Journal of Sleep Research, EarlyView.
This review explores how exposure to environmental pollutants during the first 1000 days of life may affect infant sleep. Evidence suggests potential links between chemical exposures and sleep disturbances, underscoring the need for more research on early‐life vulnerability and the impact of pollutants in air, diet, and breast milk.
Zeina Halbouty, Debora Tuka, Erwan Stephan‐Blanchard, Veronique Bach, Pierre Tourneux, Elodie Haraux, Karen Chardon   +6 more
wiley   +1 more source

Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease. [PDF]

Neurobiol Dis
Crockett RA, Casselton C, Howard TM, Wilkins KB, Seo G, Brontë-Stewart HM, Alzheimer's Disease Neuroimaging Initiative (ADNI) database.   +6 more
europepmc   +1 more source

Effects of Electroacupuncture at ST36 on Visceral Pain and Inflammatory Markers in IBS Rats

Neurogastroenterology &Motility, EarlyView.
Electroacupuncture (EA) at ST36 significantly reduced visceral pain and colonic inflammation in IBS model rats. EA increased pain thresholds, lowered AWR scores, and downregulated key inflammatory mediators (IL‐1β, IL‐6, TNF‐α, TRPV1, NF‐κB). These findings highlight ST36‐targeted EA as a promising therapeutic strategy for IBS visceral hypersensitivity
Ya‐bo Hao, Yan‐lin Liu, Xiao‐mei Wang, Kai Cheng, Qing‐yu Tu, Fei Dai, Xi‐bing Yang   +6 more
wiley   +1 more source

Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease. [PDF]

Curr Top Behav Neurosci
Russell JK, Conley AC, Wilson JE, Newhouse PA.   +3 more
europepmc   +1 more source

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Obesity Reviews, EarlyView.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani, Tzu‐Wen L. Cross, Erica de Jong, Emily S. Glover, Ivan D. Mendoza, Mojisola Adisa, Keigo Tomoo, Xinyi Zhou, Richard D. Mattes   +8 more
wiley   +1 more source

Protective role of acetylcholine and the cholinergic system in the injured heart. [PDF]

iScience
Liu Chung Ming C, Wang X, Gentile C.
europepmc   +1 more source

Non-neuronal cholinergic system delays cardiac remodelling in type 1 diabetes.

Heliyon, 2023
Munasinghe PE, Saw EL, Reily-Bell M, Tonkin D, Kakinuma Y, Fronius M, Katare R.   +6 more
europepmc   +1 more source

Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction

Obesity Reviews, EarlyView.
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey, Irene Pomares‐Bri, Paula de Juan‐Maciá, Mariló Olivares‐Vicente, Enrique Barrajón‐Catalán, Vicente Micol, Enrique Roche, María Herranz‐López   +7 more
wiley   +1 more source

The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease. [PDF]

Brain
Björklund A, Barker RA.
europepmc   +1 more source